LINC01606 and malignant colon neoplasm: Importantly, in DriverDBv3 database, the Kaplan–Meier survival analysis indicated that colon cancer patients with higher LINC01606 expression levels had a shorter 5‐year overall survival (OS) or total overall survival (5‐year‐OS: p = .0223, HR = 1.84; OS: p = .0372, HR = 1.74), progression‐free interval (5‐year‐PFI: p = .00801, HR = 1.88; PFI: p = .00399, HR = 1.96) and disease‐free interval (5‐year‐DFI: p = .00232, HR = 4.18; DFI: p = .00232, HR = 4.18) than those with lower LINC01606 expression levels.